{"id":"https://openalex.org/W4362609787","doi":"https://doi.org/10.1158/1535-7163.22505812","title":"Supplementary Tables and Figures from Targeted Delivery of Cytotoxic NAMPT Inhibitors Using Antibody\u2013Drug Conjugates","display_name":"Supplementary Tables and Figures from Targeted Delivery of Cytotoxic NAMPT Inhibitors Using Antibody\u2013Drug Conjugates","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362609787","doi":"https://doi.org/10.1158/1535-7163.22505812"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.22505812","doi":"https://doi.org/10.1158/1535-7163.22505812","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22505812","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1535-7163.22505812","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057399108","display_name":"Christopher S. Neumann","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christopher S. Neumann","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009063987","display_name":"Kathleen C. Olivas","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kathleen C. Olivas","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046639473","display_name":"Martha E. Anderson","orcid":"https://orcid.org/0009-0006-5235-1904","observed_orcids":["https://orcid.org/0009-0006-5235-1904"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Martha E. Anderson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076827864","display_name":"Julia H. Cochran","orcid":"https://orcid.org/0000-0003-3511-4254","observed_orcids":["https://orcid.org/0000-0003-3511-4254"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Julia H. Cochran","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051041499","display_name":"Steven Jin","orcid":"https://orcid.org/0000-0002-9447-8560","observed_orcids":["https://orcid.org/0000-0002-9447-8560"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steven Jin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100324312","display_name":"Fu Li","orcid":"https://orcid.org/0000-0002-0503-0052","observed_orcids":["https://orcid.org/0000-0002-0503-0052"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fu Li","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026627666","display_name":"Luke V. Loftus","orcid":"https://orcid.org/0000-0002-1564-9633","observed_orcids":["https://orcid.org/0000-0002-1564-9633"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Luke V. Loftus","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031507153","display_name":"David W. Meyer","orcid":"https://orcid.org/0000-0002-2864-3935","observed_orcids":["https://orcid.org/0000-0002-2864-3935"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David W. Meyer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020721034","display_name":"Jason R. Neale","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jason Neale","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055041718","display_name":"Jay C. Nix","orcid":"https://orcid.org/0000-0002-4041-4975","observed_orcids":["https://orcid.org/0000-0002-4041-4975"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jay C. Nix","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039508555","display_name":"Paul G. Pittman","orcid":"https://orcid.org/0000-0002-8169-9807","observed_orcids":["https://orcid.org/0000-0002-8169-9807"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul G. Pittman","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8169-9807","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022798732","display_name":"Jessica K. Simmons","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jessica K. Simmons","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019036090","display_name":"Michelle L. Ulrich","orcid":"https://orcid.org/0009-0004-3010-8212","observed_orcids":["https://orcid.org/0009-0004-3010-8212"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michelle L. Ulrich","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052715474","display_name":"Andrew B. Waight","orcid":"https://orcid.org/0000-0002-4110-1452","observed_orcids":["https://orcid.org/0000-0002-4110-1452"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew B. Waight","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024071688","display_name":"Abbie Wong","orcid":"https://orcid.org/0009-0009-4941-5921","observed_orcids":["https://orcid.org/0009-0009-4941-5921"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Abbie Wong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008955730","display_name":"Margo C. Zaval","orcid":"https://orcid.org/0009-0008-7756-9285","observed_orcids":["https://orcid.org/0009-0008-7756-9285"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Margo C. Zaval","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113745767","display_name":"Weiping Zeng","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Weiping Zeng","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036332717","display_name":"Robert P. Lyon","orcid":"https://orcid.org/0009-0008-1013-3911","observed_orcids":["https://orcid.org/0009-0008-1013-3911"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert P. Lyon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"Peter D. Senter","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter D. Senter","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.22349999845027924,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.22349999845027924,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.16740000247955322,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.16529999673366547,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nampt-inhibitors","display_name":"NAMPT inhibitors","score":0.8489999771118164},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9580000042915344},{"id":"https://openalex.org/keywords/targeted-drug-delivery","display_name":"targeted drug delivery","score":0.7699999809265137},{"id":"https://openalex.org/keywords/cytotoxic-drugs","display_name":"cytotoxic drugs","score":0.7239999771118164},{"id":"https://openalex.org/keywords/cd30","display_name":"CD30","score":0.8949999809265137},{"id":"https://openalex.org/keywords/cd19","display_name":"CD19","score":1.0},{"id":"https://openalex.org/keywords/cd123","display_name":"CD123","score":0.9980000257492065},{"id":"https://openalex.org/keywords/plasma-stability","display_name":"plasma stability","score":0.902999997138977},{"id":"https://openalex.org/keywords/crystallography","display_name":"crystallography","score":0.6340000033378601}],"concepts":[{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.5638869404792786},{"id":"https://openalex.org/C197336794","wikidata":"https://www.wikidata.org/wiki/Q5161150","display_name":"Conjugate","level":2,"score":0.5627644062042236},{"id":"https://openalex.org/C45235069","wikidata":"https://www.wikidata.org/wiki/Q278425","display_name":"Table (database)","level":2,"score":0.4910852909088135},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.4560662508010864},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3921440541744232},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.38701069355010986},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.36357825994491577},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.2471468150615692},{"id":"https://openalex.org/C124101348","wikidata":"https://www.wikidata.org/wiki/Q172491","display_name":"Data mining","level":1,"score":0.24454128742218018},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.18572962284088135},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.16450712084770203},{"id":"https://openalex.org/C134306372","wikidata":"https://www.wikidata.org/wiki/Q7754","display_name":"Mathematical analysis","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/1535-7163.22505812","doi":"https://doi.org/10.1158/1535-7163.22505812","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22505812","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1535-7163.22505812.v1","doi":"https://doi.org/10.1158/1535-7163.22505812.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22505812.v1","pdf_url":"https://aacr.figshare.com/ndownloader/files/39965809","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22505812","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Tables_and_Figures_from_Targeted_Delivery_of_Cytotoxic_NAMPT_Inhibitors_Using_Antibody_Drug_Conjugates/22505812","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.22505812","doi":"https://doi.org/10.1158/1535-7163.22505812","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22505812","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.504800021648407,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4362609787.pdf","grobid_xml":"https://content.openalex.org/works/W4362609787.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4362542104","https://openalex.org/W2890375966","https://openalex.org/W7168175440","https://openalex.org/W4282027097","https://openalex.org/W2885729424","https://openalex.org/W3083604851","https://openalex.org/W4409691220","https://openalex.org/W2810218028","https://openalex.org/W3081836603","https://openalex.org/W4252348642"],"abstract_inverted_index":{"Supplemental":[0],"tables":[1],"and":[2,14,53],"figures":[3],"referenced":[4],"in":[5,38,44],"main":[6],"text:":[7],"Table":[8,17,40],"S1":[9,24],"-":[10,19,25,32,42],"Crystallography":[11],"data":[12,47],"collection":[13],"refinement":[15],"statistics;":[16],"S2":[18,31],"ADC":[20,26,36],"characterization":[21],"data;":[22,29],"Figure":[23,30],"plasma":[27],"stability":[28],"Time":[33],"course":[34],"for":[35,48],"activity":[37],"vitro;":[39],"S3":[41],"additional":[43],"vitro":[45],"potency":[46],"ADCs":[49],"targeting":[50],"CD30,":[51],"CD19,":[52],"CD123.":[54]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-06T00:00:00"}